Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119432982 | 11943298 | 2 | F | 201509 | 20160229 | 20160125 | 20160726 | PER | US-UNITED THERAPEUTICS-UNT-2015-011741 | UNITED THERAPEUTICS | 53.38 | YR | F | Y | 104.31000 | KG | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119432982 | 11943298 | 1 | PS | TYVASO | TREPROSTINIL | 1 | 18-54 MICROGRAMS, QID | 2100687 | 22387 | INHALATION GAS | QID | ||||||||
| 119432982 | 11943298 | 2 | SS | TYVASO | TREPROSTINIL | 1 | UNK | 2100675 | 22387 | INHALATION GAS | |||||||||
| 119432982 | 11943298 | 3 | SS | TYVASO | TREPROSTINIL | 1 | UNK | 2100699 | 22387 | INHALATION GAS | |||||||||
| 119432982 | 11943298 | 4 | SS | TYVASO | TREPROSTINIL | 1 | UNK | 2100711 | 22387 | INHALATION GAS | |||||||||
| 119432982 | 11943298 | 5 | SS | TYVASO | TREPROSTINIL | 1 | 8 DF | 22387 | INHALATION GAS | ||||||||||
| 119432982 | 11943298 | 6 | SS | LETAIRIS | AMBRISENTAN | 1 | 5 MG, QD | 1403838A | 0 | 5 | MG | TABLET | QD | ||||||
| 119432982 | 11943298 | 7 | SS | LETAIRIS | AMBRISENTAN | 1 | 5 MG, QD | 1403859A | 0 | 5 | MG | TABLET | QD | ||||||
| 119432982 | 11943298 | 8 | SS | LETAIRIS | AMBRISENTAN | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET | QD | |||||||
| 119432982 | 11943298 | 9 | SS | LETAIRIS | AMBRISENTAN | 1 | Unknown | 10 MG, QD | SBFP | 0 | 10 | MG | TABLET | QD | |||||
| 119432982 | 11943298 | 10 | SS | ADEMPAS | RIOCIGUAT | 1 | Unknown | UNKNOWN | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119432982 | 11943298 | 1 | Pulmonary arterial hypertension |
| 119432982 | 11943298 | 6 | Product used for unknown indication |
| 119432982 | 11943298 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119432982 | 11943298 | Cough | |
| 119432982 | 11943298 | Diarrhoea | |
| 119432982 | 11943298 | Dizziness | |
| 119432982 | 11943298 | Dyspepsia | |
| 119432982 | 11943298 | Erythema | |
| 119432982 | 11943298 | Feeling abnormal | |
| 119432982 | 11943298 | Headache | |
| 119432982 | 11943298 | Hypotension | |
| 119432982 | 11943298 | Metabolic surgery | |
| 119432982 | 11943298 | Nausea | |
| 119432982 | 11943298 | Oxygen saturation decreased | |
| 119432982 | 11943298 | Pain in jaw | |
| 119432982 | 11943298 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119432982 | 11943298 | 1 | 20150901 | 0 | ||
| 119432982 | 11943298 | 6 | 20150825 | 0 | ||
| 119432982 | 11943298 | 9 | 20150825 | 0 |